Journal: World Journal of Stem Cells
Article Title: Targeting mesenchymal stem cell therapy for severe pneumonia patients
doi: 10.4252/wjsc.v13.i2.139
Figure Lengend Snippet: Five major perks of mesenchymal stem cells therapies for pneumonia. NO: Nitric oxide; COX2: Cyclooxygenase 2; TGF: Transforming growth factor; IL: Interleukin; EVs: Extracellular vesicles; PGE-2: Prostaglandin E2; SDF-1: Stromal cell-derived factor-1; VCAM-1: Vascular cell adhesion molecule-1; VLA-4: Very late antigen-4; MSCs: Mesenchymal stem cells; CXCR4: CXC chemokine receptor 4.
Article Snippet: NCT04366323 , Recruiting , Safety and efficacy of intravenous administration of allogeneic adult MSCs of expanded adipose tissue in patients with severe pneumonia due to COVID-19 , Allogeneic and expanded adipose tissue-derived MSCs , Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain Hospital Reina Sofía, Córdoba, Spain Hospital Universitario Virgen de las Nieves, Granada, Spain Hospital Universitario Virgen Macarena, Sevilla, Spain Hospital Unversitario Virgen del Rocío, Sevilla, Spain Hospital Nuestra Señora de Valme, Sevilla, Spain.
Techniques: Derivative Assay